Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
Example: biology
Public Assessment Report Decentralised Procedure …
Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC UK Licence No: PL 00289/2116 Teva UK Limited PAR Liothyronine Sodium 20 microgram Tablets UK/H/6516/001/DC 2 LAY SUMMARY Liothyronine Sodium 20 microgram Tablets (liothyronine sodium) This is a summary of the Public Assessment Report (PAR) for Liothyronine Sodium 20 microgram Tablets (PL 00289/2116; UK/H/6516/001/DC). It explains how Liothyronine Sodium 20 microgram Tablets were assessed and their authorisation recommended as well as their conditions of use. It is not intended to provide practical advice on how to use Liothyronine Sodium 20 microgram Tablets. For practical information about using Liothyronine Sodium 20 microgram Tablets, patients should read the package leaflet or contact their doctor or pharmacist.
Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
DECENTRALISED PROCEDURE MEMBER STATES’, DECENTRALISED PROCEDURE MEMBER STATES’ STANDARD, Procedure, Public Assessment Report Decentralised Procedure, Public Assessment Report . Decentralised Procedure, FLOW CHART OF THE DECENTRALISED, FLOW CHART OF THE DECENTRALISED PROCEDURE, All About Regulatory Affairs, Member States, Commission Regulation, Quick Response (QR) codes in the labelling and, Decentralised, EU regulatory framework and the role, REGISTER OF MEDICINAL, Register of medicinal products - frequently asked questions, QRD Human Product Information Template